Evidence map›Paper›PMID 42351268›Full record

ArticleMicrobiologyOpen2026

Carbapenem-Resistant Gram-Negative Bacilli in Mauritania: A Major Public Health Threat.

Fatimetou Ahmed Sid'Ahmed, Aminetou Mohamed Abbe, Mohamed Lemine Salem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatimetou Ahmed Sid'AhmedLaboratories of the Centre Hospitalier National de Nouakchott, Mauritania.
Aminetou Mohamed AbbeFaculty of Sciences and Technology, University of Nouakchott, Mauritania.ORCID 0000-0003-4001-9550
Mohamed Lemine SalemLaboratories of the Centre Hospitalier National de Nouakchott, Mauritania.ORCID 0000-0002-7650-7575

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant Gram-negative bacilli (CR-GNB) are an emerging public health threat due to limited treatment options. This retrospective study investigated the epidemiology and resistance patterns of CR-GNB isolated at the National Hospital Center of Nouakchott, Mauritania, between January 2020 and June 2022. Among 565 Gram-negative bacilli isolates, 25 were carbapenem-resistant, corresponding to a prevalence of 4.42%. Klebsiella pneumoniae and Escherichia coli were the most frequently identified species, and most isolates were recovered from urine samples. High resistance rates were observed to beta-lactams and fluoroquinolones, whereas colistin, tigecycline, and amikacin retained good activity. Although the prevalence remains relatively low, continuous surveillance and appropriate infection control and antimicrobial stewardship measures are required to prevent the spread of carbapenem resistance.

Indexed as

Anti-Bacterial AgentsCarbapenemsGram-Negative BacteriaGram-Negative Bacterial InfectionsColistinDrug Resistance, Multiple, BacterialEscherichia coliHumansKlebsiella pneumoniaeMauritaniaMicrobial Sensitivity TestsPrevalencePublic HealthRetrospective StudiesAnti-Bacterial AgentsCarbapenemsColistinAcinetobacter baumanniicarbapenemsenterobacteriaceaeepidemiologyPseudomonas aeruginosaresistance

Identifiers

PMID42351268
PMCPMC13303105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.